contentSlug

type

ContentSlug_ContentQuery

slug

ContentPageContentQuery

content

trendingContent

query ContentSlug_ContentQuery(
  $contentSlug: String!
  $type: [ContentType!]
) {
  ...ContentPageContentQuery_13QmVO
}

fragment CompanyDetails_Content on Content {
  __isContent: __typename
  companies {
    name
    description
    pageUrl
    id
  }
}

fragment CompanyTagList on Company {
  pageUrl
  name
  viewerIsFollowing
}

fragment ContentBasicInfo on Content {
  __isContent: __typename
  id
  type
  title
  lang
  companies {
    ...CompanyTagList
    id
  }
  ...PublishingDetails
  ...Reactions
}

fragment ContentMetadata on Content {
  __isContent: __typename
  type
  title
  lang
  pageUrl
  alternatePageUrls {
    pageUrl
    lang
  }
  imgUrl
  description
  ... on Video {
    liveTime
    videoUrl
  }
  ... on Webcast {
    liveTime
    videoUrl
  }
}

fragment ContentPageContentQuery_13QmVO on Query {
  content(slug: $contentSlug, type: $type) {
    __typename
    id
    type
    title
    isPremium
    lang
    htmlBody
    companies {
      forum {
        latestPosts {
          ...ForumPosts
        }
      }
      defaultInstrument {
        isin
        id
      }
      id
    }
    slug
    ... on CompanyReport {
      reportUrl
    }
    ... on ThirdPartyCompanyReport {
      reportUrl
    }
    ... on StockExchangeRelease {
      reportUrl
    }
    ...ContentBasicInfo
    ...ContentMetadata
    ...PriceAndRecommendation_Content
    ...CompanyDetails_Content
    ...ReportLink_Content
    ...KeyFigures_Content
  }
  ...TrendingContent_1jQ2Cn
}

fragment ForumPosts on ForumPost {
  text
  likesCount
  url
  author
  postedAt
  authorImgUrl
}

fragment KeyFigures_Content on Content {
  __isContent: __typename
  companies {
    defaultInstrument {
      estimateData {
        modelType
        reportingCurrency
      }
      snapshot {
        transaction {
          date
          actualized {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
          estimates {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
        }
      }
      id
    }
    id
  }
}

fragment PriceAndRecommendation_Content on Content {
  __isContent: __typename
  createdAt
  companies {
    id
    name
    viewerIsFollowing
    defaultInstrument {
      snapshot {
        priceData {
          date
          lastPrice
          tradeCurrency
        }
        transaction {
          date
          recommendation
          targetPrice
        }
        prevTransaction {
          recommendation
        }
      }
      id
    }
  }
}

fragment PublishingDetails on Content {
  __isContent: __typename
  createdAt
  publishers {
    name
    imgUrl
  }
  authors {
    __typename
    id
    name
    slug
    imgUrl
    jobTitle
  }
  ... on Video {
    liveTime
  }
  ... on Webcast {
    liveTime
  }
}

fragment Reactions on Content {
  __isContent: __typename
  id
  reactionGroups {
    reactionType
    reactionsCount
    viewerReacted
  }
}

fragment ReportLink_Content on Content {
  __isContent: __typename
  type
  isPremium
  ... on CompanyReport {
    reportUrl
  }
  ... on ThirdPartyCompanyReport {
    reportUrl
  }
  ... on StockExchangeRelease {
    reportUrl
  }
}

fragment TrendingContent_1jQ2Cn on Query {
  trendingContent(type: ARTICLE) {
    __typename
    id
    title
    lang
    pageUrl
    createdAt
    type
    imgUrl
    companies {
      squareLogoUrl
      id
    }
    authors {
      __typename
      imgUrl
      id
    }
    publishers {
      imgUrl
    }
  }
}


aqua-bio-technology-disclosure-of-large-shareholding

__typename

title

isPremium

lang

htmlBody

companies

createdAt

publishers

authors

reactionGroups

pageUrl

alternatePageUrls

imgUrl

description

Aqua Bio Technology

5.12.2024 08:42:59 CET | Aqua Bio Technology ASA | Major shareholding notificationsReference is made to the resolution by an extraordinary general meeting of Aqua Bio Technology ASA (the "Company...

5.12.2024 08:42:59 CET | Aqua Bio Technology ASA | Major shareholding notificationsReference is made to the resolution by an extraordinary general meeting of Aqua Bio Technology ASA (the "Company" or "ABT") to increase the Company's share capital with NOK 98,408,672.50 through the issuance of 39,636,469 new shares (the "New Shares"), each at a subscription price of NOK 3.00 and a par value of NOK 2.50.&nbsp;Following the extraordinary general meeting, Pjur Eiendom AS subscribed for 9,066,666 New Shares. Following Pjur Eiendom AS' subscription of the 9,066,666 New Shares, Pjur Eiendom AS holds a total of 11,264,123 shares and votes in the Company, representing approximately 10.35% of the outstanding votes and shares in the Company, and has thereby exceeded both the 5 % and 10 % notifiable thresholds pursuant to section 4-2 of the Norwegian Securities Trading Act.&nbsp;For further information, please contact Jan Varming, CFO, telephone +47 90 83 90 76.&nbsp;About Aqua Bio Technology ASAASA Aqua Bio Technology (ABT) is developing and commercializing sustainable biotechnology for use in skin care products. ABT's cosmetics ingredients are highly effective and they provide the cosmetics industry with natural alternatives to traditional ingredients. ABT is also marketing and distributing natural skin care products developed by partners towards consumers and professional users. Aqua Bio Technology is listed on Euronext Expand.&nbsp;This information is subject to the disclosure requirements in sections 4-2 and 5-12 of the Norwegian Securities Trading Act.<h4>Disclosure regulation</h4>This information is subject of the disclosure requirements pursuant to section of 5-12 of the Norwegian Securities Trading Act.<h4>About Aqua Bio Technology ASA</h4>Aqua Bio Technology (ABT) is developing and commercializing sustainable biotechnology for use in skin care products. ABT's cosmetics ingredients are highly effective and they provide the cosmetics industry with natural alternatives to traditional ingredients. ABT is also marketing and distributing natural skin care products developed by partners towards consumers and professional users. Aqua Bio Technology is listed on Euronext Expand.<h4>Attachments</h4><ul> <li> <a href="https://kommunikasjon.ntb.no/ir-files/17847556/18348550/5371/Download%20announcement%20as%20PDF.pdf">Download announcement as PDF.pdf</a> </li></ul>

Aqua Bio Technology: Disclosure of large shareholding

Return on capital (ROE, ROI, ROIC, RONIC)

Avkastning på kapital (ROE, ROI, ROIC, RONIC)

What does negative working capital mean and why is it a good thing?

Amazon continues to grow in Sweden

Drug development investment: Value creation through M&As and licensing agreements